San Francisco-based health data analytics company Innovaccer scored $275 million in a Series F funding round, which was a combination of primary and secondary funding.
The round brings the company's total funding to $675 million.
WHAT IT DOES
Innovaccer, founded in 2014, works with life sciences companies, government organizations, providers and payers.
Its Healthcare Intelligence Cloud is a...
California-based real-world data platform Atropos Health has secured $33 million in Series B funding.
Valtruis led the investment round, which included new investors McKesson Ventures, Merck GHI Fund and Cencora Ventures.
Existing investors Emerson Collective, Breyer Capital and Presidio Ventures also participated in the round.
Mike Spadafore, managing director of Valtruis, will join the...
Artrya secures UK, EU approvals for Salix
Within a week, ASX-listed medtech company Artrya received both regulatory approvals from the European Union and the United Kingdom for its Salix Coronary Anatomy product.
The AI-powered software identifies and analyses arterial plaque to diagnose coronary artery disease.
The recent certifications allow Artrya to market Salix in 28 EU member countries and...
